Publications

Schroers-Martin JG, Merryman R, Spinner MA, Yeung A, Chang C, Silin C, Powell M, Armand P, Shipp M, Advani R. Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma. Haematologica. 2026. PMID: 42389806

Reyes KR, Zhu R, Herberts C, Dutta P, Wray A, Mitchell B, Balkhi SS, Zhu X, Chu CE, Porten SP, Friedlander TW, Chou J, Seyedin SN, Sharma S, Malhotra M, ElNaggar AC, Liu MC, Ayanambakkam A, Koshkin VS. Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab. European urology oncology. 2026. PMID: 42379901

Desai SH, Geyer SM, Pederson L, Spinner MA, Bachanova V, Evens AM, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Chang C, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Wagner-Johnston N, Jagadeesh D, Blum KA, Diefenbach C, Iyengar S, Rappazzo KC, Baidoun F, Choi Y, Advani RH, Mocikova H, Sykorova A, Michalka J, Prochazka V, Micallef IN. Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma. Blood cancer journal. 2026. PMID: 42343091

Kimambo AH, Vuhahula E, Mmbaga EJ, Baraka BM, Malango A, Illonga Z, Mushi BP, Kitosho B, Van Loon K, Ng DL. Contextual Barriers and Facilitators to Implementing Ultrasound-Guided Fine-Needle Aspiration and Rapid Onsite Evaluation in a Resource-Limited Setting. JCO global oncology. 2026. PMID: 42269133

Llovet JM, Mauro E, Rimassa L, Mazzaferro V, Pinter M, Kelley RK, Chan SL, Kulik L, Pillai A, Roberts L, Sangro B, Casanovas T, Kaplan DE, Vogel A, Yarchoan M, Finn RS, Meyer T, Singal AG. Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement. Nature reviews. Clinical oncology. 2026. PMID: 42270817

Zeng J, Cheng Z, Chen H, Wang Z, Thompson J, Crosby KT, Han H, Singhal A, Ngo W, Xia C, Rosas-Rivera D, Zhang Z, Kang MH, Mao Y, Diolaiti ME, Lee GC, Diffley JFX, Song Y, Qiu L, Krah NM, Murthy N, Jackson RN, Liu Y, Ashworth A, Doudna JA. Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding. Nature. 2026. PMID: 42259916

Gu D, Cuby J, Gomez O, Mark H, Hall S, Stitzer M, Kushel M, Vijayaraghavan M. Money Helps: Financial Incentives for Smoking Cessation Among People Experiencing Homelessness. Substance use & misuse. 2026. PMID: 42246249

Rugo HS, Curigliano G, Cescon DW, Penault-Llorca F, Harbeck N, Im SA, Park YH, Barrios C, Modi S, Tolaney SM, Oliveira M. New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice. Breast (Edinburgh, Scotland). 2026. PMID: 42263382

Harris CS, Tsai KK, Liu L, Oppegaard KR, Cooper BA, Paul SM, Hubbard EM, Levine JD, Miaskowski CA. Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous Melanoma. Nursing research. 2026. PMID: 42228432

Raleigh D, Cady M, Aggarwal A, Stevers N, Zakimi N, Liu I, Mirchia K, Coukos J, Kongpracha P, Zhou Y, Nguyen M, Braman B, Leclair N, Phillips J, Chow K, Shamdasani-Sen S, Chantousti N, Choi B, Hong C, Toedebusch R, Englander R, Frankus J, Sinha D, Karner H, Rosenbluth J, Veer LV', Choudhury A, Liu SJ, Krogan N, Costello J, Anczuków O, Toedebusch C, Dickinson P, Goodarzi H, Swaney D. A proteogenomic RNA processing mechanism drives sex differences in meningioma. Research square. 2026. PMID: 42282014

Chatterjee A, Mustafa Ali MK, Bailey CM, Liu Y, Small D, Smith CC, Traer E, Wang Y, Silvestri G, Baer MR. Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors. Leukemia. 2026. PMID: 42230959

McConathy J, Koshkin VS, Menda Y, Rodon J, Goenka AH, Moy RH, Morse S, Demange A, Blumenstein L, Babaoglan B, Aimone P, Hope TA. Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42223513

Aggarwal R, Oseran AS, Manrai AK, Marinacci LX, Bhatt DL, Yeh RW, Ho JE, Rodman A, Wadhera RK. Performance of Local Large Language Models for Adjudicating Heart Failure Hospitalizations. Circulation. 2026. PMID: 42224376

Kennedy VE, Peretz CAC, Walia A, Chyla B, Sun Y, Hill JE, Tran E, Koh AD, Ferng TT, Pintar S, Jones M, Popescu B, Lomeli I, Chehab F, Murad N, John A, Roy RP, Olshen AB, Berryhill CA, Davis C, Angus SP, Rivera JM, Meshulam A, Stieglitz E, Joshi SK, Traer E, Dail M, Hamidi H, Altman JK, Daver NG, Levis MJ, McCloskey J, Perl AE, Smith CC. Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy. Blood. 2026. PMID: 42224378

Beumer A, Carlson M, Arcuri AL, Maues J, Cowden J, Walker S, Shanahan K, Collins JL, Veach AJ, Rugo HS, Burkard ME, Kalinsky KM, Bardia A, Lustberg MB, Papautsky EL, Roberson ML. A Patient-Led Survey of Antibody Drug Conjugate Usage and Dosing for People Living With Metastatic Breast Cancer. Journal of Patient Experience. 2026. PMID: 42227000

Malangwa G, Banzi MO, Makupa G, Nnko G, Mwakipunda L, Rugengemanzi E, Karia A, Ramadhan A, Mashashi G, Idrisa C, Gisiri M, Kashabano J, Mabruk NA, Moturi M, Mushi B, Ndumbalo J, Kahesa C, Maunda K, DeBoer RJ, Mmbaga E, Lugina EL. The social and clinical profile of patients with ocular surface squamous cell carcinoma in Tanzania. BMC cancer. 2026. PMID: 42218433

Dent S, Nadler MB, Blaes A, Iqbal A, Ayettey HNG, Alvarez-Cardona J, Chan A, Koh ES, Mascunano RC, George M, Aryeetey NA, Howden EJ, Kazuhiro S, Latif N, Ozaki AF, Semple CJ, Ramalingan T, Iyenger NM, Rugo HS, Koczwara B. Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026. PMID: 42209784

Aggarwal RR, Italiano A, Domchek SM, Goodman O, Postel-Vinay S, García-Donás J, Dorff T, Reichert ZR, Vinceneux A, Shore N, Marshall CH, Armenia J, Parr G, Kmieciak A, Lukashchuk N, Murina O, Slade D, Shah N, Loembé B, Dean E, Sanai E, Abida W. Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study. Cancer Research Communications. 2026. PMID: 42219553

Ramesh R, Osorio RC, Pekmezci M, Boreta L, Datta D, Alan N. Diagnosis and Management of Extranodal Rosai-Dorfman Disease Isolated to the Thoracic Spine: Systematic Review and Illustrative Case. World neurosurgery. 2026. PMID: 42214468

Hawes MR, Safier J, Clark B, Pamatmat M, Bonniot C, Cheng C, Almazar R, Gillece J, Vijayaraghavan M. Implementing Trauma-Informed Training for Tobacco Use for Health Care Professionals in Two California Counties. Health promotion practice. 2026. PMID: 42187031